Search Results - "Muthian, S."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Anandamide content is increased and CB 1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia by Muthian, S., Rademacher, D.J., Roelke, C.T., Gross, G.J., Hillard, C.J.

    Published in Neuroscience (2004)
    “…The role of endocannabinoid signaling in the response of the brain to injury is tantalizing but not clear. In this study, transient middle cerebral artery…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia by MUTHIAN, S, RADEMACHER, D. J, ROELKE, C. T, GROSS, G. J, HILLARD, C. J

    Published in Neuroscience (2004)
    “…The role of endocannabinoid signaling in the response of the brain to injury is tantalizing but not clear. In this study, transient middle cerebral artery…”
    Get full text
    Journal Article
  5. 5

    Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry by Tsou, Kang, Nogueron, M.Isabel, Muthian, Shanmugam, Sañudo-Peña, M.Clara, Hillard, Cecilia J, Deutsch, Dale G, Walker, J.Michael

    Published in Neuroscience letters (02-10-1998)
    “…The distribution in the rat brain of fatty acid amide hydrolase (FAAH) an enzyme that catalyzes the hydrolysis of the endogenous cannabinoid anandamide was…”
    Get full text
    Journal Article
  6. 6

    Effects of CB1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity by Hillard, Cecilia J, Muthian, Shanmugam, Kearn, Christopher S

    Published in FEBS letters (08-10-1999)
    “…Cerebellar granule cells (CGCs) express the CB1 subtype of cannabinoid receptor. CB1 receptor agonists Win 55212‐2, CP55940 and HU210 inhibit KCl‐induced…”
    Get full text
    Journal Article
  7. 7

    Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier by Muthian, S, Nithipatikom, K, Campbell, W B, Hillard, C J

    “…N-Arachidonoylethanolamine (AEA) is a proposed endogenous ligand of the central cannabinoid receptor (CB1). Previous studies indicate that AEA is translocated…”
    Get more information
    Journal Article
  8. 8

    The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat by PATEL, Sachin, GERRITS, Ronald, MUTHIAN, Shanmugam, GREENE, Andrew S, HILLARD, Cecilia J

    Published in Neuroscience letters (25-12-2002)
    “…Several recent studies have demonstrated a neuromodulatory role for endocannabinoids via their ability to act as retrograde inhibitors of synaptic…”
    Get full text
    Journal Article
  9. 9

    Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity by Hillard, C J, Muthian, S, Kearn, C S

    Published in FEBS letters (08-10-1999)
    “…Cerebellar granule cells (CGCs) express the CB(1) subtype of cannabinoid receptor. CB(1) receptor agonists Win 55212-2, CP55940 and HU210 inhibit KCl-induced…”
    Get full text
    Journal Article
  10. 10

    Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase by Edgemond, W S, Greenberg, M J, McGinley, P J, Muthian, S, Campbell, W B, Hillard, C J

    “…N-Arachidonylethanolamine (AEA), a putative endogenous agonist of neuronal (CB1) cannabinoid receptors, is a substrate for N-arachidonylethanolamine…”
    Get more information
    Journal Article